Page last updated: 2024-10-22

aristolochic acid i and Glomerulonephritis, Lupus

aristolochic acid i has been researched along with Glomerulonephritis, Lupus in 1 studies

aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donadei, C1
Angeletti, A1
Cantarelli, C1
D'Agati, VD1
La Manna, G1
Fiaccadori, E1
Horwitz, JK1
Xiong, H1
Guglielmo, C1
Hartzell, S1
Madsen, JC1
Maggiore, U1
Heeger, PS1
Cravedi, P1

Other Studies

1 other study available for aristolochic acid i and Glomerulonephritis, Lupus

ArticleYear
Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.
    JCI insight, 2019, 04-23, Volume: 5

    Topics: Animals; Aristolochic Acids; Cells, Cultured; Disease Models, Animal; Epoetin Alfa; Erythropoietin;

2019